International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 10 , ISSUE 3 ( September-December, 2019 ) > List of Articles

RESEARCH ARTICLE

Prenatal Diagnosis and Management of Fetal Goiter: A Case Series from Tertiary Perinatal Center in South India

Manjula Budidapadu, Suseela Vavilala, Geeta Kolar

Keywords : Congenital hypothyroidism, Cord blood thyroid-stimulating hormone, Fetal goiter, Fetal therapy, Intra-amniotic levothyroxine

Citation Information : Budidapadu M, Vavilala S, Kolar G. Prenatal Diagnosis and Management of Fetal Goiter: A Case Series from Tertiary Perinatal Center in South India. Int J Infertil Fetal Med 2019; 10 (3):37-41.

DOI: 10.5005/jp-journals-10016-1187

License: CC BY-NC 4.0

Published Online: 23-11-2020

Copyright Statement:  Copyright © 2019; The Author(s).


Abstract

Aims and objectives: The reported incidence of fetal goiter is 1 in 40,000 live births. The effects of fetal goiter and thyroid dysfunction are significant. The objective of our study is to assess the safety, feasibility, and efficacy of intra-amniotic instillation of levothyroxine (LT4) in fetal goitrous hypothyroidism. Materials and methods: A retrospective observational study of prenatally diagnosed cases of fetal goiter on routine antenatal ultrasound between January 2010 and January 2018 at Fernandez Hospital Foundation, Hyderabad, tertiary perinatal referral center. Data retrieved from electronic database. Results: During this period, 9 cases of fetal goiter were diagnosed on routine ultrasonography with the incidence of 1 in 7,000 live births. The gestation age at diagnosis ranged between 21 weeks and 29 weeks (mean 26 weeks). Of the nine fetuses with goiter, two were excluded as one ended in a miscarriage at 22 weeks and the other was terminated elsewhere at 26 weeks. Data were analyzed in the remaining seven fetuses. Cordocentesis was performed in five fetuses and amniocentesis was performed in one woman with dichorionic diamniotic (DCDA) twin gestation which revealed hypothyroid status. Fetal therapy was offered to all the remaining seven fetuses with intra-amniotic instillation of LT4 100 to 200 μg at 2–3 weeks’ interval. First dose of LT4 was given at mean gestation of 27 weeks (range 23–30 weeks), and the mean time between the identification of fetal goiter and the first dose of LT4 was 6 days (range 2–15 days). Number of injections given ranged between 1 and 7. No adverse events were recorded. Follow-up sonogram showed subjective reduction in the goiter size. All the babies had hypothyroidism at birth. Conclusion: Our case series confirms the safety and feasibility of intra-amniotic instillation of LT4 for fetal goitrous hypothyroidism. Although fetal therapy has resulted in reduction in the size of the goiter, the thyroid hormone levels at birth were low. Further research is required to establish the proper management guidelines for this disorder.


HTML PDF Share
  1. Treatment of fetal goitrous hypothyroidism: Value of direct intramuscular L-thyroxine therapy. Prenat Diagn 2010;30(9):899–901. DOI: 10.1002/pd.2560.
  2. Normal fetal thyroid volume. Ultrasound Obstet Gynecol 1998;11(2):118–122. DOI: 10.1046/j.1469-0705.1998.11020118.x.
  3. The development of the foetal thyroid: in utero ultrasonographic measurements. Clin Endocrinol (Oxf) 1998;48(3):259–264. DOI: 10.1046/j.1365-2265.1998.00388.x.
  4. Ultrasonography of the fetal thyroid: nomograms based on biparietal diameter and gestational age. J Ultrasound Med 2001;20(6):613–617. DOI: 10.7863/jum.2001.20.6.613.
  5. Sonographic detection of fetal goitre, an unusual cause of hydramnios. J Ultrasound Med 1985;4(11):625–627. DOI: 10.7863/jum.1985.4.11.625.
  6. Antenatal diagnosis and treatment of a fetal goitre. J Reprod Med 1980;24(1):39–42.
  7. The importance of iodine nutrition during pregnancy. Public Health Nutr 2007;10(12A):1542–1546. DOI: 10.1017/S1368980007360886.
  8. Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab 2004;18(2):289–302. DOI: 10.1016/j.beem.2004.03.009.
  9. Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725G–A [R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol Metab 2003; 8(8):3546–3553. DOI: 10.1210/jc.2002-021744.
  10. Prenatal diagnosis and treatment of dyshormonogenetic fetal goitre due to defective thyroglobulin synthesis. J Clin Endocrinol Metab 1997;82(12):4239–4242. DOI: 10.1210/jcem.82.12.4407.
  11. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 2009;68(4):609–617. DOI: 10.1111/j.1365-2125.2009.03495.x.
  12. Successful in utero treatment of fetalgoitre and hypothyroidism. N Engl J Med 1991;324(8):543–546. DOI: 10.1056/NEJM199102213240807.
  13. Elementary school performance of children with congenital hypothyroidism. J Pediatr 1990;116(1):27–32. DOI: 10.1016/s0022-3476(05)81640-3.
  14. Biochemical investigation of foetal and neonatal thyroid function using the ACS180SE analyser: clinical application. Ann Clin Biochem 2001;38(Pt 5):520–526. DOI: 10.1177/000456320103800509.
  15. Establishment of reference intervals for markers of fetal thyroid status in amniotic fluid. J Clin Endocrinol Metab 2003;88(9):4175–4179. DOI: 10.1210/jc.2003-030522.
  16. Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. Fetal Diagn Ther 2001;16(1):47–51. DOI: 10.1159/000053880.
  17. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989; 32(1):13–16. DOI: 10.1056/NEJM198907063210103.
  18. Inherited disorders of the thyroid system. Boca Raton-CRC Pres 1994. 1–218.
  19. Managment of fetal goitres: a case report of 11 cases in a single perinatal unit. Prenat Diagn 2000;20(10):799–806. DOI: 10.1002/1097-0223(200010)20:103.0.co;2-v.
  20. Prenatal diagnosis and intrapartum management of neck masses causing airway obstruction. Paediatr Anaesth 2004;14(1):48–52. DOI: 10.1046/j.1460-9592.2003.01201.x.
  21. Use of ultrasound to distinguish between fetal hyperthyroidism and hypothyroidism on discovery of a goiter. Ultrasound Obstet Gynecol 2009;33(4):412–420. DOI: 10.1002/uog.6315.
  22. Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of the literature. Ultrasound ObstetGynecol 1995;6(5):368–371. DOI: 10.1046/j.1469-0705.1995.06050368.x.
  23. Prenatal diagnosis and early in utero management of fetal dyshormonogenetic goitre. Eur J Obstet Gynecol Reprod Biol 2001;94(2):309–314. DOI: 10.1016/s0301-2115(00)00346-8.
  24. Thyroid hormones in amniotic fluid. Am J Clin Pathol 2007;128(1):158–163. DOI: 10.1309/69A5AV266W230AUA.
  25. Antenatal diagnosis and treatment of a dyshormonogenetic fetal goitre. J Ultrasound Med 2009;28(1):67–71. DOI: 10.7863/jum.2009.28.1.67.
  26. Intrauterine diagnosis and management of fetal goitrous hypothyroidism: a report of an Iranian family with three consecutive pregnancies complicated by fetal goitre. Thyroid. 2005;15(12):1341–1347. DOI: 10.1089/thy.2005.15.1341.
  27. Fetal treatment for early dyshormonogenetic goitre. Prenat Diagn 2009;29(5):543–545. DOI: 10.1002/pd.2237.
  28. Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. J Clin Endocrin Metab 1990;71(3):618–621. DOI: 10.1210/jcem-71-3-618.
  29. Use of 3-dimensional sonography for prenatal evaluation and follow-up of fetal goitrous hypothyroidism. J Ultrasound Med 2010;29(9):1339–1343. DOI: 10.7863/jum.2010.29.9.1339.
  30. Three-dimensional sonography in the evaluation and management of fetal goitre. Ultrasound Obstet Gynecol 2005;25(3):312–314. DOI: 10.1002/uog.1863.
  31. Experience with intraamniotic thyroxine treatment in nonimmune fetal goitrous hypothyroidism in 12 cases. J Clin Endocrinol Metab October;94(10):3731–3739. DOI: 10.1210/jc.2008-2681.
  32. Alternatives to the antenatal glucocorticoid treatment for the prevention of respiratory distress syndrome. J Perinat Med 1987;15(5):453–459. DOI: 10.1515/jpme.1987.15.5.453.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.